...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Embargo
Reply New Message
Back To Forum List View
Embargo
2
Hartland
Mar 30, 2017 03:34PM
Icon president Re: Embargo
2
BearDownAZ
Mar 30, 2017 04:15PM
Icon president Re: Embargo
3
BearDownAZ
Mar 31, 2017 10:31AM

Does anyone expect we may hear something positive comeout of this late breaking abstract for the phase 1 Zen 3694 trial, if the trial failed why would they start go on to the combo trial,  

 

Anyone think we may a good surprise NR before the late breaking abstract?

1 Recommendations
Icon president Re: Embargo
2
BearDownAZ
Mar 31, 2017 11:36AM
Re: Embargo
3
tada
Mar 31, 2017 12:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply